Intrepid Potash (NYSE:IPI) has outperformed the market over the past 5 years by 23.69% on an annualized basis producing an average annual return of 37.63%. Currently, Intrepid Potash has a market capitalization of $1.10 billion.
Gainers
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
What Defines a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Intrepid Potash (NYSE:IPI) reported quarterly earnings of $16.66 per share. This is a 33420 percent increase over losses of $(0.05) per share from the same period last year.